Novitium Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVITIUM PHARMA
NOVITIUM PHARMA has one hundred and fifteen approved drugs.
There are three US patents protecting NOVITIUM PHARMA drugs. There is one tentative approval on NOVITIUM PHARMA drugs.
Summary for Novitium Pharma
| US Patents: | 3 |
| Tradenames: | 100 |
| Ingredients: | 99 |
| NDAs: | 115 |
| Patent Litigation for Novitium Pharma: | See patent lawsuits for Novitium Pharma |
Drugs and US Patents for Novitium Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 077807-001 | Dec 28, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 216383-002 | Aug 29, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | TAPENTADOL HYDROCHLORIDE | tapentadol hydrochloride | SOLUTION;ORAL | 219119-001 | Jan 26, 2026 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Novitium Pharma | KETOCONAZOLE | ketoconazole | SHAMPOO;TOPICAL | 218498-001 | Sep 16, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 077550-001 | May 14, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
